Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Wang, Qihui, Zhang, Yanfang, Wu, Lili, Niu, Sheng, Song, Chunli, Zhang, Zengyuan, Lu, Guangwen, Qiao, Chengpeng +6 more·2020·Cell
DOI 10.1016/j.cell.2020.03.045

Cited by (1,009)

Items 701–800 of 1,009

  1. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells
    Jinfeng Peng, Jiwei Sun, Jiajia Zhao, Xuliang Deng, Fengyuan Guo, Lili Chen · 2021 · Journal of Translational Medicine
  2. Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
    Javeed Ahmad, Jiansheng Jiang, Lisa F. Boyd, Allison Zeher, Rick K Huang, Di Xia, Kannan Natarajan, David H. Margulies · 2021 · Journal of Biological Chemistry
  3. Principles of SARS-CoV-2 glycosylation
    Himanshi Chawla, Elisa Fadda, Max Crispin · 2022 · Current Opinion in Structural Biology
  4. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy
    Jun Sun · 2020 · Medical Hypotheses
  5. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
    Lu Lu, Allen Wing‐Ho Chu, Ruiqi Zhang, Wan-Mui Chan, Jonathan Daniel Ip, Hoi‐Wah Tsoi, Lin‐Lei Chen, Jian‐Piao Cai, David Christopher Lung, Anthony Raymond Tam et al. · 2021 · EBioMedicine
  6. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
    Zhen-Lin Yang, Yulu Wang, Yu-jia Jin, Yuan-Fei Zhu, Yan-Ling Wu, Cheng Li, Yu Kong, Wen-Ping Song, Xiaolong Tian, Wuqiang Zhan et al. · 2021 · Signal Transduction and Targeted Therapy
  7. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection
    Luigi Rosa, Antimo Cutone, Maria Pia Conte, Elena Campione, Luca Bianchi, Piera Valenti · 2022 · BioMetals
  8. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0
    Silvia I. Gervasoni, Giulio Vistoli, Carmine Talarico, Candida Manelfi, Andrea R. Beccari, Gabriel Studer, Gerardo Tauriello, Andrew Mark Waterhouse, Torsten F. Schwede, Alessandro Pedretti · 2020 · International Journal of Molecular Sciences
  9. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
    Ge Li, Aiping Wang, Yumei Chen, Yaning Sun, Yongkun Du, Xun Wang, Peiyang Ding, Rui Jia, Yanwei Wang, Gaiping Zhang · 2021 · Frontiers in Immunology
  10. Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry
    Wenlin Ren, Yunkai Zhu, Yuyan Wang, Hongyang Shi, Yu Yin, Gaowei Hu, Fei Feng, Xiaomin Zhao, Jun Lan, Jianping Wu et al. · 2021 · PLoS Pathogens
  11. Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses
    Jianhui Nie, Qianqian Li, Li Zhang, Yang Cao, Yue Zhang, Tao Li, Jiajing Wu, Shuo Liu, Mengyi Zhang, Chenyan Zhao et al. · 2021 · Cell Discovery
  12. SARS-CoV-2 Disease through Viral Genomic and Receptor Implications: An Overview of Diagnostic and Immunology Breakthroughs
    Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antônio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco et al. · 2021 · Microorganisms
  13. The Anti-Infectious Role of Sphingosine in Microbial Diseases
    Yuqing Wu, Yongjie Liu, Erich Gulbins, Heike Grassmé · 2021 · Cells
  14. Nanomedicine based approaches for combating viral infections
    Saurabh Shah, Mahavir Bhupal Chougule, Arun Kumar Kotha, Rama Kashikar, Chandraiah Godugu, Rajeev Singh Raghuvanshi, Shashi Bala Singh, Saurabh Srivastava · 2021 · Journal of Controlled Release
  15. Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
    Veronica Di Sarno, Gianluigi Lauro, Simona Musella, Tania Ciaglia, Vincenzo Vestuto, Marina Sala, Maria Carmina Scala, Gerardina Smaldone, Francesca Di Matteo, Sara Novi et al. · 2021 · European Journal of Medicinal Chemistry
  16. Phage Display-Derived Peptide for the Specific Binding of SARS-CoV-2
    Fan Yang, Li Liu, Pierre Fernand Neuenschwander, Steven Idell, Ramakrishna Vankayalapati, Krishan Gopal Jain, Ke Du, Hong‐Long Ji, Guohua Yi · 2021 · ACS Omega
  17. Genetic Landscape of the ACE2 Coronavirus Receptor
    Zhijian Yang, Erin Macdonald-Dunlop, Jiantao Chen, Ranran Zhai, Ting Li, Anne Richmond, Lucija Klarić, Nicola Pirastu, Zheng Ning, Chenqing Zheng et al. · 2022 · Circulation
  18. The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour
    A. S. Oliveira, D. Shoemark, Amaurys Avila Ibarra, A. Davidson, I. Berger, C. Schaffitzel, A. Mulholland · 2021 · bioRxiv
  19. Membrane attachment and fusion of HIV-1, influenza A, and SARS-CoV-2: resolving the mechanisms with biophysical methods
    Geetanjali Negi, Anurag Sharma, Manorama Dey, Garvita Dhanawat, Nagma Parveen · 2022 · Biophysical Reviews
  20. 40 minutes RT-qPCR Assay for Screening Spike N501Y and HV69-70del Mutations
    Gülay Korukluoğlu, Mustafa Kolukırık, Fatma Bayrakdar, Gozde Girgin Ozgumus, Ayşe Başak Altaş, Yasemin Coşgun, Canan Zohre Ketre Kolukirik · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  21. SMOG 2 and OpenSMOG: Extending the limits of structure‐based models
    Antonio Bento de Oliveira Junior, Vinícius G. Contessoto, Asem H. Hassan, Sandra Byju, Ailun Wang, Yang Wang, Esteban Dodero‐Rojas, Udayan Mohanty, Jeffrey K. Noel, José N. Onuchic et al. · 2021 · Protein Science
  22. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
    Mohammed Ghalib Enayathullah, Yash Parekh, Sarena Banu, Sushma Ram, Ramakrishnan Nagaraj, Bokara Kiran Kumar, Mohammed M. Idris · 2022 · Scientific Reports
  23. Synthetic Nanobody-Functionalized Nanoparticles for Accelerated Development of Rapid, Accessible Detection of Viral Antigens
    Xiahui Chen, Shoukai Kang, Md Ashif Ikbal, Zhi Gao Zhao, Yuxin Pan, Jiawei Zuo, Liangcai Gu, Chao Wang · 2021 · Biosensors and Bioelectronics
  24. Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19
    Cristine Dieter, Letícia de Almeida Brondani, Natália Emerim Lemos, Ariell Freires Schaeffer, Caroline Zanotto, Denise Taurino Ramos, Eliandra Girardi, Felipe Mateus Pellenz, Joíza Lins Camargo, Karla Suzana Moresco et al. · 2022 · Genes
  25. Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19
    Zahra Shabani, Jialing Liu, Hua Su · 2023 · Biology
  26. Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients
    María José Lizardo-Thiebaud, Eduardo Cervantes‐Alvarez, Nathaly Limon‐de la Rosa, Farid Tejeda‐Dominguez, Mildred Palacios-Jiménez, Osvely Méndez-Guerrero, Marco Antonio Delaye-Martínez, Fátima Rodríguez-Álvarez, Beatriz Romero-Morales, Weihui Liu et al. · 2020 · Seminars in Liver Disease
  27. A Hydrophobic‐Interaction‐Based Mechanism Triggers Docking between the SARS‐CoV‐2 Spike and Angiotensin‐Converting Enzyme 2
    Jiacheng Li, Xiaoliang Ma, Shuai Guo, Chengyu Hou, Liping Shi, Hongchi Zhang, Bing Zheng, Chenchen Liao, Lin Yang, Lin Ye et al. · 2020 · Global Challenges
  28. Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak
    Zheng Zhang, Ji Chen, Jung-hua Wang, Qiao Gao, Zhu-Jun Ma, Shu-Rong Xu, Li Zhang, J. Cai, Wei-Chang Zhou · 2020 · Biotechnology progress (Print)
  29. Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
    L. Karpenko, A. P. Rudometov, S. V. Sharabrin, D. Shcherbakov, M. B. Borgoyakova, S. Bazhan, E. Volosnikova, N. Rudometova, L. A. Orlova, I. Pyshnaya et al. · 2021 · Vaccines
  30. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
    Fabrizio Maggi, Alfredo Rosellini, Pietro Giorgio Spezia, Daniele Focosi, Lisa Macera, Michele Lai, Mauro Pistello, Antonio de Iure, Carlo Tomino, Stefano Bonassi et al. · 2021 · ERJ Open Research
  31. Ultrasound and Doppler findings in pregnant women with SARS‐CoV ‐2 infection
    Eleazar E. Soto, Edgar A. Hernandez‐Andrade, Erin S. Huntley, Hector Mendez Figueroa, Sean C. Blackwell · 2021 · Ultrasound in Obstetrics and Gynecology
  32. Should we discount the laboratory origin of COVID-19?
    Rossana Segreto, Yuri Deigin, Kevin McCairn, Alejandro Sousa, Dan Sirotkin, Karl M. Sirotkin, Jonathan J. Couey, Adrian Jones, Daoyu Zhang · 2021 · Environmental Chemistry Letters
  33. Design and synthesis of pyrazolone-based compounds as potent blockers of SARS-CoV-2 viral entry into the host cells
    Vincent Adeiza Obakachi, Narva Deshwar Kushwaha, Babita Kushwaha, Mavela Cleopus Mahlalela, Suraj Shinde, Idowu A. Kehinde, Rajshekhar V. Karpoormath · 2021 · Journal of Molecular Structure
  34. N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation
    Wenyang Zhou, Chang Xu, Pingping Wang, Meng Luo, Zhaochun Xu, Rui Cheng, Xiyun Jin, Yu Guo, Guangfu Xue, Liran Juan et al. · 2021 · Frontiers in Cell and Developmental Biology
  35. S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
    Fei Ye, Xi Lin, Zimin Chen, Fanli Yang, Sheng Lin, Jing Yang, Hua Chen, Honglu Sun, Lingling Wang, Ao Wen et al. · 2021 · Signal Transduction and Targeted Therapy
  36. A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
    Huan Ma, Xinghai Zhang, Weihong Zeng, Junhui Zhou, Xiangyang Chi, Shaohong Chen, Peiyi Zheng, Meihua Wang, Yan Wu, Dan Zhao et al. · 2022 · Cell Discovery
  37. Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
    Halie M. Rando, Adam L. MacLean, Alexandra J. Lee, Ronan Lordan, Sandipan Ray, Vikas Bansal, Ashwin N. Skelly, Elizabeth Sell, John J. Dziak, Lamonica Shinholster et al. · 2021 · mSystems
  38. Human genetic basis of coronavirus disease 2019
    H. Deng, Xue Yan, La-Mei Yuan · 2021 · Signal Transduction and Targeted Therapy
  39. Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae
    Stefano Pallanti, Eleonora Grassi, Nikos Makris, Gregory P. Gasic, Eric Hollander · 2020 · Journal of Psychiatric Research
  40. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation
    Uma Sankar Gorla, Koteswara Rao, Uma Sankar Kulandaivelu, Rajasekhar Reddy Alavala, Siva Prasad Panda · 2020 · Combinatorial Chemistry & High Throughput Screening
  41. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
    Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Sara Paone, Miriam Scicchitano, Roberta Macrì, Saverio Nucera, Francesca Bosco et al. · 2020 · International Journal of Molecular Sciences
  42. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2
    Harlan R. Barker, Seppo Parkkila · 2020 · PLoS ONE
  43. In silico mutagenesis of human ACE2 with S protein and translational efficiency explain SARS-CoV-2 infectivity in different species
    Javier Delgado, Xavier Hernandez‐Alias, Damiano Cianferoni, Luis G. Serrano · 2020 · PLoS Computational Biology
  44. Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations
    Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka · 2021 · RSC Advances
  45. Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients
    Paolo Poggio, Paola Songia, Chiara Vavassori, Veronica Ricci, Cristina Banfi, Silvia Stella Barbieri, Gloria Garoffolo, Veronika A. Myasoedova, Luca Piacentini, Angela Raucci et al. · 2021 · Scientific Reports
  46. A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
    Eun Ran Kim, Florian J. Weisel, Stephen C. Balmert, Muhammad S. Khan, Shaohua Huang, Géza Erdös, Thomas W. Kenniston, Cara Donahue Carey, Stephen M. Joachim, Laura J. Conter et al. · 2021 · European Journal of Immunology
  47. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls
    Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, Lis M. Yapanto, Mohsen Nabi‐Afjadi, Mohsen Aksoun, Maryam Nasr Esfahani, Fatemeh Aghakhani, Mahsa Movahed et al. · 2021 · International Immunopharmacology
  48. An in silico scientific basis for LL ‐37 as a therapeutic for Covid‐19
    Kiran Bharat Lokhande, Tanushree Banerjee, K. Venkateswara Swamy, Payel Ghosh, Manisha S. Deshpande · 2021 · Proteins Structure Function and Bioinformatics
  49. The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione
    Mana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, Asuka Kobayashi, Masumi Houri, Tetsuya Inoue, Takuya Irie, Ryutaro Gemba, Yosuke Kondo, Yoshio Nakano et al. · 2022 · Biochemical and Biophysical Research Communications
  50. Genetic landscape of the ACE2 coronavirus receptor
    Zhijian Yang, Erin Macdonald-Dunlop, Jiantao Chen, Bram Peter Prins, Eleanor Wheeler, Maik Pietzner, James E. Peters, Claudia Langenberg, Adam S. Butterworth, Alex P. Reiner et al. · 2022 · Apollo (University of Cambridge)
  51. Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
    Qingrui Huang, Xiaonan Han, Jinghua Yan · 2022 · Emerging Microbes & Infections
  52. Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor
    Bengül Durmaz, Olkar Abdulmajed, Rıza Durmaz · 2020 · Medeniyet Medical Journal
  53. Allosteric Cross-Talk among Spike’s Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor
    Angelo Spinello, Andrea Saltalamacchia, Jure Borišek, Alessandra Magistrato · 2021 · The Journal of Physical Chemistry Letters
  54. Structural Analysis of the SARS-CoV-2 Omicron Variant Proteins
    Qiangzhen Yang, Ali Alamdar Shah Syed, Aamir Fahira, Yongyong Shi · 2021 · Research
  55. BL02U1: the relocated macromolecular crystallography beamline at the Shanghai Synchrotron Radiation Facility
    Ke Liu, Huan Zhou, Qin Lan Xu, Huating Kong, Kunhao Zhang, Weiwei Wang, Min-Jun Li, Zhijun Wang, Qiang-Yan Pan, Xing-Ya Wang et al. · 2023 · Nuclear Science and Techniques
  56. Early-Morning vs Spot Posterior Oropharyngeal Saliva for Diagnosis of SARS-CoV-2 Infection: Implication of Timing of Specimen Collection for Community-Wide Screening
    Derek L.L. Hung, Xin Li, Kelvin Hei‐Yeung Chiu, Cyril Chik‐Yan Yip, Kelvin Kai‐Wang To, Jasper Fuk‐Woo Chan, Siddharth Sridhar, Tom Wai‐Hin Chung, Kwok-Cheung Lung, Raymond Wai To Liu et al. · 2020 · Open Forum Infectious Diseases
  57. An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection
    Carina Conzelmann, Andrea Gilg, Rüdiger M. Groß, Desirée Schütz, Nico Preising, Ludger Ständker, Bernd Jahrsdörfer, Hubert Schrezenmeier, Konstantin M. J. Sparrer, Thomas Stamminger et al. · 2020 · Antiviral Research
  58. In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
    Chidi Edbert Duru, Ijeoma Akunna Duru, Abayomi Emmanuel Adegboyega · 2021 · Bulletin of the National Research Centre/Bulletin of the National Research Center
  59. Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses
    Li Wang, Xiaoyu Fan, Gaston Bonenfant, Dan Cui, Jaber Hossain, Nannan Jiang, Gloria P. Larson, Michael Currier, Jimma Liddell, Malania M. Wilson et al. · 2021 · Emerging infectious diseases
  60. Therapeutic Potential of Glycosyl Flavonoids as Anti-Coronaviral Agents
    Patrícia I. C. Godinho, Raquel G. Soengas, Vera L. M. Silva · 2021 · Pharmaceuticals
  61. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study
    Kirsten Cameron, Lina Rozano, Marco Falasca, Ricardo L. Mancera · 2021 · International Journal of Molecular Sciences
  62. Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera
    Vishal S. Patil, Vrushabh B Hupparage, Ajay P Malgi, Sanjay Deshpande, Sathgowda A. Patil, Shamanand P. Mallapur · 2021 · Chinese Herbal Medicines
  63. Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2
    Juan Ángel Patiño-Galindo, Ioan Filip, Ratul Chowdhury, Costas D. Maranas, Peter Karl Sorger, Mohammed AlQuraishi, Raúl Rabadán · 2021 · Genome Medicine
  64. Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
    Puya Dehgani‐Mobaraki, Asiya Kamber Zaidi, Nidhi Yadav, A. Floridi, Emanuela Floridi · 2021 · Clinical Immunology
  65. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2
    Raymond R. R. Rowland, Alberto Brandariz-Núñez · 2021 · Microbiology Spectrum
  66. Aptamers—Diagnostic and Therapeutic Solution in SARS-CoV-2
    Tomasz Wandtke, Ewelina Wędrowska, Marcin Szczur, Grzegorz Przybylski, Marek Libura, Piotr Kopiński · 2022 · International Journal of Molecular Sciences
  67. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy
    Harry F. Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis, Irene Ligielli, Graham J. Moore, Laura Kate Gadanec, Anthony Zulli, Vasso Apostolopoulos, Thomas Mavromoustakos, John Matsoukas · 2022 · Viruses
  68. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
    Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Samir Haj Bloukh, Zehra Edis, Majid Sharifi, Ehsan Kachooei, Mojtaba Falahati · 2020 · Journal of Biomolecular Structure and Dynamics
  69. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
    Jun Wu, Xiaohui Yuan, Bing Wang, Rui Gu, Wei Li, Xuemei Xiang, Lijun Tang, Hongyu Sun · 2020 · Frontiers in Microbiology
  70. Drugs acting on the renin–angiotensin system and SARS-CoV-2
    Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara · 2021 · Drug Discovery Today
  71. Adaptive Evolution of the Spike Protein in Coronaviruses
    Xiaolu Tang, Zhaohui Qian, Xuemei Lu, Jian Lü · 2023 · Molecular Biology and Evolution
  72. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
    Hongming Zhang, Kelly Quek, Runzhe Chen, Jibei Chen, Baoan Chen · 2020 · Journal of Cancer
  73. Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis
    Priyanka Sharma, Asifkhan Shanavas · 2020 · Journal of Biomolecular Structure and Dynamics
  74. Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology
    Stephen J. Fairweather, Nishank Shah, Stefan Bröer · 2020 · Advances in experimental medicine and biology
  75. In silico Investigation on the Inhibiting Role of Nicotine/Caffeine by Blocking the S Protein of SARS-CoV-2 Versus ACE2 Receptor
    Saeedeh Mohammadi, Mohammad Heidarizadeh, Mehrnaz Entesari, Ayoub Esmailpour, Mohammad Esmailpour, Rasoul Moradi, Nader Sakhaee, Esmail Doustkhah · 2020 · Microorganisms
  76. Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam
    Tam Thi Nguyen, Thach Ngoc Pham, Trang Dinh Van, Trang Thu Nguyen, Diep Thi Ngoc Nguyen, Hoa Nguyen Minh Le, John‐Sebastian Eden, Rebecca J. Rockett, Thuong Thi Nguyen, Bich Thi Ngoc Vu et al. · 2020 · PLoS ONE
  77. Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity
    Shokouh Rezaei, Yahya Sefidbakht, Vuk Uskoković · 2020 · Journal of Biomolecular Structure and Dynamics
  78. The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2
    Pei Shan Li, Ruixuan Guo, Yan Liu, Yingtao Zhang, Jiaxin Hu, Xiuyuan Ou, Dan Mi, Ting Chen, Zhixia Mu, Yelin Han et al. · 2021 · 中国科学通报：英文版
  79. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment
    Shasank Sekhar Swain, Satya Ranjan Singh, Alaka Sahoo, Tahziba Hussain, Sanghamitra Pati · 2021 · Journal of Biomolecular Structure and Dynamics
  80. Cell surface detection of vimentin, ACE2 and SARS-CoV-2 Spike proteins reveals selective colocalization at primary cilia
    Vasiliki S. Lalioti, Silvia González-Sanz, Irene Lois-Bermejo, Patricia González-Jiménez, Álvaro Viedma-Poyatos, Andrea Merino, Marı́a A. Pajares, Dolores Pérez‐Sala · 2022 · Scientific Reports
  81. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
    Yunjeong Kim, Natasha N. Gaudreault, David A. Meekins, Krishani Dinali Perera, Dashzeveg Bold, Jessie D. Trujillo, Igor Morozov, Chester D. McDowell, Kyeong‐Ok Chang, Jüergen A. Richt · 2022 · Microbiology Spectrum
  82. Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps
    Jonathan Whisenant, Kevin Burgess · 2020 · ACS Medicinal Chemistry Letters
  83. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities
    Manisha Yadav, Swasti Dhagat, Satya Eswari · 2020 · European Journal of Pharmaceutical Sciences
  84. ACE2 partially dictates the host range and tropism of SARS-CoV-2
    Shan Gao, Leiliang Zhang · 2020 · Computational and Structural Biotechnology Journal
  85. Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization “Hotspots” in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction
    Dominic Narang, D. Andrew James, Matthew T. Balmer, Derek J. Wilson · 2021 · Journal of the American Society for Mass Spectrometry
  86. Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection
    Nidhi Shukla, Sarah M. Roelle, Vinicius G. Suzart, Anna M. Bruchez, Kenneth A. Matreyek · 2021 · PLoS Pathogens
  87. Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases
    Yesi Shi, Hongyan Qian, Peishi Rao, Dan Mu, Yuan Liu, Gang Liu, Zhong‐Ning Lin · 2021 · Acta Pharmaceutica Sinica B
  88. Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
    Jagat Narayan Shah, Guang‐Qin Guo, Anand Krishnan, Muthusamy Ramesh, Naresh Kumar Katari, Mohd Shahbaaz, Magda H. Abdellattif, Sachin Kumar Singh, Kamal Dua · 2021 · Therapies
  89. Identification of potent small molecule inhibitors of SARS-CoV-2 entry
    Sonia Mediouni, Huihui Mou, Yuka Otsuka, Joseph Anthony Jablonski, Robert Scott Adcock, Lalit Batra, Dong-Hoon Chung, Christopher Rood, Ian Mitchelle S. de Vera, Ronald J. Jr. Rahaim et al. · 2022 · SLAS DISCOVERY
  90. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs
    Andrzej S. Tarnawski, Amrita Ahluwalia · 2022 · World Journal of Gastroenterology
  91. Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys
    Heng Li, Lei Guo, Hui-Wen Zheng, Jing Li, Xin Zhao, Jia-Qi Li, Yan Liang, Fengmei Yang, Yu-Rong Zhao, Jin-Ling Yang et al. · 2021 · Bioconjugate chemistry
  92. Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development
    Kunchur Guruprasad · 2022 · Current Research in Structural Biology
  93. Peptide-Based Vaccines and Therapeutics for COVID-19
    Pritam V. Bagwe, Priyal Bagwe, Sai Srinivas Ponugoti, Shreerang V. Joshi · 2022 · International Journal of Peptide Research and Therapeutics
  94. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
    Chao Su, Juanhua He, Pengcheng Han, Bin Bai, Dedong Li, Jian Xin Cao, Mingxiong Tian, Yu Hu, Anqi Zheng, Sheng Niu et al. · 2022 · Journal of Virology
  95. Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule
    Fernando Luís Barroso da Silva, Carolina Corrêa Giron, Aatto Laaksonen · 2022 · The Journal of Physical Chemistry B
  96. Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein
    Xiaodong Luan, Xinming Li, Yufan Li, Gengchen Su, Wanchao Yin, Yi Jiang, Ning Xu, Feng Wang, Chéng Wáng, Jin Ye et al. · 2022 · 中国科学通报：英文版
  97. Vimentin is an important ACE2 co-receptor for SARS-CoV-2 in epithelial cells
    Jeffrey Arrindell, Perla Abou Atmeh, Laurie Jayet, Youssouf Sérémé, Jean‐Louis Mège, Benoît Desnues · 2022 · iScience
  98. Drug Repurposing: a Shortcut to New Biological Entities
    Nutan Rao, Tushar Poojari, Charvi Poojary, Ruksar Sande, Sonal Sawant · 2022 · Pharmaceutical Chemistry Journal
  99. High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification
    Isabelle Dugail, Ez‐Zoubir Amri, Nicolas Vitale · 2020 · Biochimie
  100. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
    Xia Rao, Runchu Zhao, Zhou Tong, Shuxin Guo, Weiyu Peng, Kefang Liu, Shihua Li, Lili Wu, Jianyu Tong, Yan Chai et al. · 2023 · Proceedings of the National Academy of Sciences